Want to see HK:0239 full AI Analyst Report?
Pak Fah Yeow International Limited (0239) Stock Price & Analysis
0239 Stock Chart & Stats
- Day’s Range
- HKD 2.35 - HKD 2.50
- 52-Week Range
- HKD 2.24 - HKD 2.73
- Previous Close
- HKD 2.49
- Volume
- 52.50K
- Average Volume (3M)
- 18.58K
- Market Cap
- HKD 774.43M
- Enterprise Value
- HKD 348.39M
- Total Cash (Recent Filing)
- HKD 400.27M
- Total Debt (Recent Filing)
- HKD 6.95M
- Price to Earnings (P/E)
- 7.8
- Beta
- -0.05
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 29, 2026
- Dividend Yield
- 7.44%
Bulls Say, Bears Say
Bulls Say
Strong Profitability
Sustained high profitability across recent years indicates a resilient branded consumer-health business with strong earnings conversion. This provides internal funding capacity and can support marketing, product maintenance and distribution investment over the next several quarters.
Very Low Leverage
The conservative balance sheet limits interest and refinancing risk while preserving flexibility. Low leverage should help the company withstand demand fluctuations, meet regulatory or operating needs, and sustain shareholder distributions without excessive financial strain.
Robust Recent Cash Generation
Strong recent operating and free cash flow, generally tracking net income, supports the quality of reported earnings. Reliable internal cash generation can fund inventory, distribution and brand investment while reducing dependence on external financing.
Bears Say
Revenue Volatility
Uneven top-line performance makes the earnings base less predictable and may reflect sensitivity to product demand, geographic mix or distribution volumes. Persistent revenue volatility could limit operating leverage and make future margin strength harder to sustain.
Inconsistent Historical Returns
The contrast between strong recent returns and weak earlier periods shows that profitability is not fully consistent through the cycle. This history suggests the brand and business model remain exposed to changing demand or operating conditions despite the current balance-sheet strength.
Volatile Cash Flow
Although recent cash generation is strong, historical swings and the decline in 2024 reduce confidence that cash conversion will remain smooth. Missing or zero latest-period coverage fields also limit confirmation of liquidity and payout sustainability.
Pak Fah Yeow International Limited News
Pak Fah Yeow Wins Strong Shareholder Backing for Dividends, Mandates and Bye-law Changes
Pak Fah Yeow International Limited ( ($HK:0239) ) just unveiled an announcement. Shareholders of Pak Fah Yeow International Limited overwhelmingly approved all resolutions at the 2 June 2026 annual general
0239 FAQ
What was Pak Fah Yeow International Limited’s price range in the past 12 months?
What is Pak Fah Yeow International Limited’s market cap?
When is Pak Fah Yeow International Limited’s upcoming earnings report date?
How were Pak Fah Yeow International Limited’s earnings last quarter?
Is Pak Fah Yeow International Limited overvalued?
Does Pak Fah Yeow International Limited pay dividends?
What is Pak Fah Yeow International Limited’s EPS estimate?
How many shares outstanding does Pak Fah Yeow International Limited have?
What happened to Pak Fah Yeow International Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Pak Fah Yeow International Limited?
What is the TipRanks Smart Score and how is it calculated?
Pak Fah Yeow International Limited Stock Smart Score
Company Description
Pak Fah Yeow International Limited
Pak Fah Yeow International Limited, operating with its subsidiaries, specializes in the production, promotion, and distribution of healthcare goods under the Hoe Hin brand. Its market reach spans the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and other international territories. The company's operations are categorized into three distinct divisions: Healthcare, Property Investments, and Treasury Investments. Among its key offerings are medicated oils, such as white flower embrocation, along with various ointments and solutions for strain relief, including the floral-scented Fúzai 239 white flower embrocation. Beyond its primary healthcare focus, the firm also commits capital to diverse real estate assets, encompassing commercial, industrial, residential, and car park properties, and additionally provides advertising agency services. This enterprise, established in 1927, maintains its corporate headquarters in Wan Chai, Hong Kong.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wee Sean Gan
- Employees
- 100
- Website
- www.pakfahyeow.com
- Address
- HK
Pak Fah Yeow International Limited (0239) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 3 | 6 |
| Technical Analysis | 2 | 3 | 5 |
| Moving Averages | 11 | 0 | 1 |







